SCHEMBL25952460

SCHEMBL25952460

COCOc1ccc(/C=C/C(=O)c2c(O)c(C)c(OCOC)c(C)c2OC)cc1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 2/20 0.60
▸ MAPT P10636 3/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ KCNA3 P22001 2/20 0.47
▸ SLC5A1 P13866 2/20 0.46
▸ SLC5A2 P31639 2/20 0.46
▸ MAOB P27338 3/20 0.44
▸ ABCG2 Q9UNQ0 3/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ F3 P13726 1/20 0.42
▸ P4HB P07237 1/20 0.41
▸ CALM1 P0DP23 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25342585 1.00 ABCB1 (0.60) ABCB1MAPTTDP1ALDH1A1LMNA
SCHEMBL25952463 0.95 ABCB1 (0.60) ABCB1MAPTTDP1ALDH1A1LMNA
SCHEMBL25339626 0.95 ABCB1 (0.60) ABCB1MAPTTDP1ALDH1A1LMNA
SCHEMBL25952509 0.93 ABCB1 (0.58) ABCB1MAPTTDP1ALDH1A1LMNA
SCHEMBL25952507 0.92 ABCB1 (0.61) ABCB1MAPTTDP1ALDH1A1LMNA
SCHEMBL25339313 0.92 ABCB1 (0.61) ABCB1MAPTTDP1ALDH1A1LMNA
SCHEMBL25952454 0.92 ABCB1 (0.61) ABCB1MAPTTDP1ALDH1A1LMNA
SCHEMBL25952499 0.90 ABCB1 (0.57) ABCB1MAPTTDP1ALDH1A1LMNA
SCHEMBL25341084 0.90 ABCB1 (0.59) ABCB1MAPTTDP1ALDH1A1LMNA
SCHEMBL25429661 0.90 ABCB1 (0.59) ABCB1MAPTTDP1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248665-A1 COMPOSITION COMPRISING DIMETHYLCHALCONE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION (KR) 2023-08-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248665-A1 COMPOSITION COMPRISING DIMETHYLCHALCONE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE LIPC, PC, CYP27A1 ABCB1 3180/4885MAPT 1563/4885TDP1 3927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback